Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2026-04-19 @ 4:21 AM
Study NCT ID:
NCT00002495
Status:
COMPLETED
Last Update Posted:
2017-02-20
First Post:
1999-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease
Sponsor:
SWOG Cancer Research Network
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
CDR0000077691
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None